Clinical Study

Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma

Table 3

Distribution of interstitial lung disease (ILD) through connective tissue diseases (CTD).

PM/DM 𝑛 (%)SLE 𝑛 (%)SjΓΆgren 𝑛 (%)Mixed CTD 𝑛 (%)U CTD 𝑛 (%)P Neo 𝑛 (%)P

ILD11 (64.7)6 (69.7)1 (50)5 (62.5)2 (66.7)1 (50)0.996*

PM/DM, polymyositis dermatomyositis; SLE, systemic lupus erythematosus; CTD, connective tissue diseases; U, undifferentiated; P Neo, paraneoplastic.
*Fischer test.